May 19, 2017 / 12:04 PM / in 7 months

BRIEF-EU Medicines Agency recommends against approval of AB Science mastocytosis drug Masitinib

May 19 (Reuters) - EU Medicines Agency:

* EU Medicines Agency recommends approval of Valeant Pharmaceuticals Inc psoriasis drug Brodalumab

* EU Medicines Agency recommends approval of Richter Gedeon and Recordati Industria Chimica E Farmaceutica SPA Cariprazine drug for bipolar mania and schizophrenia

* EU Medicines Agency recommends against approval of AB Science mastocytosis drug Masitinib Source text ID: (bit.ly/2qAKgbz) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below